首页 > 最新文献

Middle East African Journal of Ophthalmology最新文献

英文 中文
Surgical Audit for the Outcome of Primary Rhegmatogenous Retinal Detachment Repair in the Kingdom of Bahrain. 巴林王国对原发性风湿性视网膜脱离修复术结果的手术审计。
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-06-14 eCollection Date: 2023-04-01 DOI: 10.4103/meajo.meajo_200_22
Maryam Almohsen, Razan Shehab, Ahmed Asal, Fatema Alqassab
<p><strong>Purpose: </strong>The purpose of the study was to audit the primary and final success rate for primary rhegmatogenous retinal detachment (RRD) surgery performed between 2017 and 2022 at the Department of Ophthalmology in Salmanyia Medical Complex, the Kingdom of Bahrain. In addition, secondary outcomes for our study include assessments of risk factors for recurrence, final visual outcomes and complication rates.</p><p><strong>Methods: </strong>Prospective observational study showed data analysis of case series for 75 RRD patients operated during the study period. All patients who met the inclusion criteria were included in the study and evaluated by a specialized vitreoretinal surgeon before and after their operation. All patients were operated by the same surgeon (M.A) in the study period. Data collected from the hospital's electronic medical recording system (I-Seha) include macular state, pre- and postoperative best-corrected visual acuity, duration of symptoms, the presence of proliferative vitreoretinopathy (PVR), retinal breaks and their locations, any ocular comorbidities associated in the perioperative period such as increase in intraocular pressure or development of cataract, and operative notes related to the type of primary, secondary, and tertiary surgery if needed.</p><p><strong>Results: </strong>A total number of 70 eyes from 70 patients with the majority of male patients (74.28%, n = 52) were included in the study. The mean age of the participants was 54.75 years (range: 11-91 years). Most of the patients 48.57% presented within 6 days of symptoms. Nearly 77.1% of the operated cases were macula off, whereas 22.85% were macula on. Thirty-six of the eyes (51.4%) had complex RRD with a combination of PVR (34.2%). Sixty-three of the eyes (51.4%) underwent standard 23G pars plana vitrectomy, while the combined surgery with a scleral buckle was performed on 9 eyes (12.8%). Five patients underwent pneumatic retinopexy and two patients had primary scleral buckles. Combined phacoemulsification with vitrectomy in selected cases was performed on 13 eyes (18.5%). Different tamponading agents were used 35 eyes (50%) silicon oil, 17 eyes (24%) C3F8, and 18 eyes (25%) SF6. The primary reattachment rate after one operation was 77.1% (54 eyes). The final reattachment rate following a second or third procedure was 95.7%. The mean postoperative visual acuity was 6/18 (range: 6/6 to hand motions). Thirty percent of the cohort of patients had a visual acuity of 6/12 or better. Sixteen out of the 70 eyes redetached (22.8%) and 10 of those eyes (62.5%) were classified as "complex" preoperatively which is thought to be a significant risk factor for failure.</p><p><strong>Conclusion: </strong>Our audit overall met international success rates despite the presence of some complex scenarios which required multiple surgical interventions. The primary use of gas or silicon oil did not influence reattachment rates but had a statistical significance wh
目的:本研究旨在对巴林王国萨尔曼尼亚医疗中心眼科部 2017 年至 2022 年期间实施的原发性流变性视网膜脱离(RRD)手术的初次成功率和最终成功率进行审核。此外,我们研究的次要结果包括评估复发风险因素、最终视觉结果和并发症发生率:前瞻性观察研究对研究期间接受手术的 75 例 RRD 患者的系列病例进行了数据分析。所有符合纳入标准的患者均被纳入研究,并在手术前后接受了玻璃体视网膜专科医生的评估。在研究期间,所有患者均由同一位外科医生(M.A)进行手术。从医院的电子医疗记录系统(I-Seha)中收集的数据包括黄斑状态、术前和术后最佳矫正视力、症状持续时间、是否存在增殖性玻璃体视网膜病变(PVR)、视网膜破损及其位置、围手术期的任何眼部合并症(如眼压升高或白内障发展),以及与一级、二级和三级手术类型(如需要)相关的手术记录:研究共纳入了 70 名患者的 70 只眼睛,其中男性患者占大多数(74.28%,n = 52)。参与者的平均年龄为 54.75 岁(范围:11-91 岁)。大多数患者 48.57% 在出现症状 6 天内就诊。近 77.1%的手术病例黄斑脱落,22.85%的手术病例黄斑开启。其中 36 只眼睛(51.4%)患有复杂的 RRD,并合并有 PVR(34.2%)。63只眼睛(51.4%)接受了标准的23G玻璃体旁切除术,9只眼睛(12.8%)接受了巩膜扣带联合手术。五名患者接受了气动视网膜整形术,两名患者接受了原发性巩膜扣带术。有 13 只眼睛(18.5%)在选定病例中进行了联合乳化和玻璃体切割手术。使用了不同的填塞剂:35 只眼睛(50%)使用硅油,17 只眼睛(24%)使用 C3F8,18 只眼睛(25%)使用 SF6。一次手术后的初次再粘连率为 77.1%(54 只眼)。第二次或第三次手术后的最终再接合率为 95.7%。术后平均视力为 6/18(范围:6/6 至手势)。30%的患者视力达到或超过 6/12。70只眼睛中有16只(22.8%)再次脱落,其中10只(62.5%)在术前被归类为 "复杂",这被认为是失败的重要风险因素:尽管存在一些需要多次手术干预的复杂情况,但我们的审计总体上达到了国际成功率。主要使用气体或硅油并不影响再粘连率,但对最终视觉效果有统计学意义。
{"title":"Surgical Audit for the Outcome of Primary Rhegmatogenous Retinal Detachment Repair in the Kingdom of Bahrain.","authors":"Maryam Almohsen, Razan Shehab, Ahmed Asal, Fatema Alqassab","doi":"10.4103/meajo.meajo_200_22","DOIUrl":"10.4103/meajo.meajo_200_22","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;The purpose of the study was to audit the primary and final success rate for primary rhegmatogenous retinal detachment (RRD) surgery performed between 2017 and 2022 at the Department of Ophthalmology in Salmanyia Medical Complex, the Kingdom of Bahrain. In addition, secondary outcomes for our study include assessments of risk factors for recurrence, final visual outcomes and complication rates.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Prospective observational study showed data analysis of case series for 75 RRD patients operated during the study period. All patients who met the inclusion criteria were included in the study and evaluated by a specialized vitreoretinal surgeon before and after their operation. All patients were operated by the same surgeon (M.A) in the study period. Data collected from the hospital's electronic medical recording system (I-Seha) include macular state, pre- and postoperative best-corrected visual acuity, duration of symptoms, the presence of proliferative vitreoretinopathy (PVR), retinal breaks and their locations, any ocular comorbidities associated in the perioperative period such as increase in intraocular pressure or development of cataract, and operative notes related to the type of primary, secondary, and tertiary surgery if needed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total number of 70 eyes from 70 patients with the majority of male patients (74.28%, n = 52) were included in the study. The mean age of the participants was 54.75 years (range: 11-91 years). Most of the patients 48.57% presented within 6 days of symptoms. Nearly 77.1% of the operated cases were macula off, whereas 22.85% were macula on. Thirty-six of the eyes (51.4%) had complex RRD with a combination of PVR (34.2%). Sixty-three of the eyes (51.4%) underwent standard 23G pars plana vitrectomy, while the combined surgery with a scleral buckle was performed on 9 eyes (12.8%). Five patients underwent pneumatic retinopexy and two patients had primary scleral buckles. Combined phacoemulsification with vitrectomy in selected cases was performed on 13 eyes (18.5%). Different tamponading agents were used 35 eyes (50%) silicon oil, 17 eyes (24%) C3F8, and 18 eyes (25%) SF6. The primary reattachment rate after one operation was 77.1% (54 eyes). The final reattachment rate following a second or third procedure was 95.7%. The mean postoperative visual acuity was 6/18 (range: 6/6 to hand motions). Thirty percent of the cohort of patients had a visual acuity of 6/12 or better. Sixteen out of the 70 eyes redetached (22.8%) and 10 of those eyes (62.5%) were classified as \"complex\" preoperatively which is thought to be a significant risk factor for failure.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Our audit overall met international success rates despite the presence of some complex scenarios which required multiple surgical interventions. The primary use of gas or silicon oil did not influence reattachment rates but had a statistical significance wh","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 2","pages":"80-84"},"PeriodicalIF":0.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238933/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term Follow-up Results of Idiopathic Epiretinal Membrane Removal in the Eyes with Ectopic Inner Foveal Retinal Layers. 异位内眼窝视网膜膜摘除术的长期随访结果
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-06-14 eCollection Date: 2023-04-01 DOI: 10.4103/meajo.meajo_51_24
Ecem O Tokuc, Levent Karabas, Ilkay K Muftuoglu, Sevim A Seyyar

Purpose: The purpose of this study was to evaluate pre- and perioperative factors related to time for the evolution of ectopic inner foveal layers (EIFL) following pars plana vitrectomy (PPV) for epiretinal membrane (ERM) peeling.

Methods: This retrospective study included 81 consecutive eyes with idiopathic ERM that underwent vitrectomy surgery. Standard PPV + internal limiting membrane peeling was performed in all cases. A comprehensive ophthalmic examination was performed for all patients before and 1, 3, 6, and 12 months, and the last follow-up after surgery. We observed the postoperative improvement in EIFL severity in the short-term and longest follow-up and evaluated anatomical and functional improvement. Several parameters were assessed using the multivariate COX proportional hazard analysis.

Results: Eighty patients (81 eyes) with a mean age of 70.33 ± 7.75 years were followed for a mean of 34.37 ± 23.61 months, and 55.5% of eyes (45 eyes) with EIFL ERM showed improvement of foveal contour to a better stage at the last follow-up. The median estimated time for evolving to a better stage was 29.73 months for stage 2, 49.68 months for stage 3, and 38.67 months for stage 4 (P = 0.001, log-rank test). The severity of EIFL was the only significant factor for time to evolution of EIFL ERM to a better stage, where the eyes with stage 4 EIFL ERM showed faster foveal contour improvement compared to those with stage 3 EIFL ERM (hazard ratio: 0.317, 95% confidence interval = 0.164-0.615, P = 0.001).

Conclusion: On assessing preoperative factors, the preoperative EIFL stage emerged as the sole significant factor for EIFL ERM improvement to a better disease stage. This study reports some of the longest follow-up durations for patients undergoing PPV for EIFL ERM, and both functional and anatomical improvements were observed across all stages of EIFL, including in the advanced stage 4 EIFL ERM.

目的:本研究旨在评估因视网膜外膜(ERM)剥离而进行玻璃体旁切除术(PPV)后,与异位眼窝内层(EIFL)演变时间相关的术前和围手术期因素:这项回顾性研究纳入了81只接受玻璃体切除手术的特发性ERM患者。所有病例均进行了标准 PPV + 内缘膜剥离术。术前、术后1个月、3个月、6个月、12个月以及最后一次随访时,对所有患者进行了全面的眼科检查。我们观察了术后短期和长期随访中 EIFL 严重程度的改善情况,并评估了解剖和功能改善情况。我们使用多变量 COX 比例危险分析评估了几个参数:80名患者(81眼)的平均年龄为(70.33±7.75)岁,平均随访时间为(34.37±23.61)个月,55.5%的EIFL ERM患者(45眼)在最后一次随访时眼窝轮廓改善到了较好的阶段。估计发展到较好阶段的中位时间为:2期 29.73 个月,3期 49.68 个月,4期 38.67 个月(P = 0.001,对数秩检验)。EIFL的严重程度是EIFL ERM向较好阶段演变时间的唯一显著因素,与EIFL ERM 3期的患者相比,EIFL ERM 4期的患者眼窝轮廓改善更快(危险比:0.317,95%置信区间=0.164-0.615,P=0.001):结论:在评估术前因素时,术前EIFL分期是EIFL ERM好转至较佳疾病分期的唯一重要因素。该研究报告了对接受PPV治疗的EIFL ERM患者进行的一些最长的随访时间,观察到所有阶段的EIFL,包括晚期4期EIFL ERM,在功能和解剖学上都有所改善。
{"title":"Long-term Follow-up Results of Idiopathic Epiretinal Membrane Removal in the Eyes with Ectopic Inner Foveal Retinal Layers.","authors":"Ecem O Tokuc, Levent Karabas, Ilkay K Muftuoglu, Sevim A Seyyar","doi":"10.4103/meajo.meajo_51_24","DOIUrl":"10.4103/meajo.meajo_51_24","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to evaluate pre- and perioperative factors related to time for the evolution of ectopic inner foveal layers (EIFL) following pars plana vitrectomy (PPV) for epiretinal membrane (ERM) peeling.</p><p><strong>Methods: </strong>This retrospective study included 81 consecutive eyes with idiopathic ERM that underwent vitrectomy surgery. Standard PPV + internal limiting membrane peeling was performed in all cases. A comprehensive ophthalmic examination was performed for all patients before and 1, 3, 6, and 12 months, and the last follow-up after surgery. We observed the postoperative improvement in EIFL severity in the short-term and longest follow-up and evaluated anatomical and functional improvement. Several parameters were assessed using the multivariate COX proportional hazard analysis.</p><p><strong>Results: </strong>Eighty patients (81 eyes) with a mean age of 70.33 ± 7.75 years were followed for a mean of 34.37 ± 23.61 months, and 55.5% of eyes (45 eyes) with EIFL ERM showed improvement of foveal contour to a better stage at the last follow-up. The median estimated time for evolving to a better stage was 29.73 months for stage 2, 49.68 months for stage 3, and 38.67 months for stage 4 (<i>P</i> = 0.001, log-rank test). The severity of EIFL was the only significant factor for time to evolution of EIFL ERM to a better stage, where the eyes with stage 4 EIFL ERM showed faster foveal contour improvement compared to those with stage 3 EIFL ERM (hazard ratio: 0.317, 95% confidence interval = 0.164-0.615, <i>P</i> = 0.001).</p><p><strong>Conclusion: </strong>On assessing preoperative factors, the preoperative EIFL stage emerged as the sole significant factor for EIFL ERM improvement to a better disease stage. This study reports some of the longest follow-up durations for patients undergoing PPV for EIFL ERM, and both functional and anatomical improvements were observed across all stages of EIFL, including in the advanced stage 4 EIFL ERM.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 2","pages":"72-79"},"PeriodicalIF":0.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238928/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Dorzolamide-timolol Eye drop on Intraocular Pressure Change in Intravitreal Ranibizumab Injected Patients. 多佐胺-噻吗洛尔滴眼液对注射玻璃体内雷珠单抗患者眼压变化的影响
IF 0.5 Q4 OPHTHALMOLOGY Pub Date : 2024-06-14 eCollection Date: 2023-04-01 DOI: 10.4103/meajo.meajo_177_23
Mehmet Coşkun

Purpose: The objective of the study was to examine the effect of dorzolamide-timolol (DT) eye drop used before intravitreal ranibizumab (IVR) injection on intraocular pressure (IOP) change.

Methods: 50 eyes of 50 patients who received DT eye drops 1 h before IVR injection due to diabetic retinopathy and macular edema were considered Group 1, and 50 eyes of 50 patients who did not receive DT eye drops were considered Group 2. Those patients who had previously undergone intravitreal injection had intraocular surgery, and used any eye drops were not included in the study. Before the injection, IOP values were measured with a Tonopen contact handheld tonometer before the blepharostat was placed (BIOP), after the blepharostat was placed (AIOP), and at the 1st min after the injection (IIOP).

Results: There were 25 males and 25 females in Group 1 and 25 males and 25 females in Group 2; the mean age was 65.66 ± 9.94 years in Group 1 and 65.54 ± 7.43 years in Group 2 (P = 0.98). In Group 1, BIOP was 18.91 ± 18.91, AIOP was 21.62 ± 6.16 mmHg, and IIOP was 49.21 ± 10.95 mmHg. In Group 2, BIOP was 20.18 ± 4.19 mmHg, AIOP was 24.60 ± 4.90 mmHg, and IIOP was 49.96 ± 9.72 mmHg. IIOP-BIOP difference was 30.30 ± 9.85 mmHg in Group 1 and 29.78 ± 9.33 mmHg in Group 2 and the difference was not statistically significant (P = 0.78). In Group 1, the IIOP-AIOP difference was 27.58 ± 10.60 mmHg and in Group 2, 25.36 ± 10.46 mmHg. The difference between IIOP and AIOP was not statistically significant (P = 0.27).

Conclusion: The use of topical DT eye drops before IVR injection does not affect the intraocular pressure change.

目的:该研究旨在探讨玻璃体内注射雷尼珠单抗(IVR)前使用多佐胺-噻吗洛尔(DT)滴眼液对眼压(IOP)变化的影响。方法:将因糖尿病视网膜病变和黄斑水肿而在注射 IVR 前 1 小时滴用多佐胺-噻吗洛尔(DT)眼药水的 50 名患者的 50 只眼睛视为第一组,未滴用 DT 眼药水的 50 名患者的 50 只眼睛视为第二组。注射前,使用 Tonopen 接触式手持眼压计测量放置眼睑板前(BIOP)、放置眼睑板后(AIOP)和注射后 1 分钟(IIOP)的眼压值:第一组有 25 名男性和 25 名女性,第二组有 25 名男性和 25 名女性;第一组的平均年龄为(65.66 ± 9.94)岁,第二组的平均年龄为(65.54 ± 7.43)岁(P = 0.98)。第 1 组的 BIOP 为(18.91±18.91)mmHg,AIOP 为(21.62±6.16)mmHg,IIOP 为(49.21±10.95)mmHg。第二组的 BIOP 为 20.18 ± 4.19 mmHg,AIOP 为 24.60 ± 4.90 mmHg,IIOP 为 49.96 ± 9.72 mmHg。第 1 组 IIOP-BIOP 差值为 30.30 ± 9.85 mmHg,第 2 组为 29.78 ± 9.33 mmHg,差异无统计学意义(P = 0.78)。第 1 组的 IIOP-AIOP 差值为 27.58 ± 10.60 mmHg,第 2 组为 25.36 ± 10.46 mmHg。IIOP 和 AIOP 之间的差异无统计学意义(P = 0.27):结论:IVR 注射前局部滴用 DT 眼药水不会影响眼压变化。
{"title":"The Effect of Dorzolamide-timolol Eye drop on Intraocular Pressure Change in Intravitreal Ranibizumab Injected Patients.","authors":"Mehmet Coşkun","doi":"10.4103/meajo.meajo_177_23","DOIUrl":"10.4103/meajo.meajo_177_23","url":null,"abstract":"<p><strong>Purpose: </strong>The objective of the study was to examine the effect of dorzolamide-timolol (DT) eye drop used before intravitreal ranibizumab (IVR) injection on intraocular pressure (IOP) change.</p><p><strong>Methods: </strong>50 eyes of 50 patients who received DT eye drops 1 h before IVR injection due to diabetic retinopathy and macular edema were considered Group 1, and 50 eyes of 50 patients who did not receive DT eye drops were considered Group 2. Those patients who had previously undergone intravitreal injection had intraocular surgery, and used any eye drops were not included in the study. Before the injection, IO<i>P</i> values were measured with a Tonopen contact handheld tonometer before the blepharostat was placed (BIOP), after the blepharostat was placed (AIOP), and at the 1<sup>st</sup> min after the injection (IIOP).</p><p><strong>Results: </strong>There were 25 males and 25 females in Group 1 and 25 males and 25 females in Group 2; the mean age was 65.66 ± 9.94 years in Group 1 and 65.54 ± 7.43 years in Group 2 (<i>P</i> = 0.98). In Group 1, BIOP was 18.91 ± 18.91, AIOP was 21.62 ± 6.16 mmHg, and IIOP was 49.21 ± 10.95 mmHg. In Group 2, BIOP was 20.18 ± 4.19 mmHg, AIOP was 24.60 ± 4.90 mmHg, and IIOP was 49.96 ± 9.72 mmHg. IIOP-BIOP difference was 30.30 ± 9.85 mmHg in Group 1 and 29.78 ± 9.33 mmHg in Group 2 and the difference was not statistically significant (<i>P</i> = 0.78). In Group 1, the IIOP-AIOP difference was 27.58 ± 10.60 mmHg and in Group 2, 25.36 ± 10.46 mmHg. The difference between IIOP and AIOP was not statistically significant (<i>P</i> = 0.27).</p><p><strong>Conclusion: </strong>The use of topical DT eye drops before IVR injection does not affect the intraocular pressure change.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 2","pages":"85-88"},"PeriodicalIF":0.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11238931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refractive Changes among Diode Laser-treated Retinopathy of Prematurity Patients: A Retrospective Study. 接受二极管激光治疗的早产儿视网膜病变患者的屈光变化:一项回顾性研究
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2024-01-22 eCollection Date: 2023-01-01 DOI: 10.4103/meajo.meajo_117_23
Lujain Alqurashi, Albaraa Alfaraidi, Faeeqah Almahmoudi, Enam Danish, Manal Hadrawi

Purpose: The purpose of this study was to assess the refractive outcomes of patients who underwent indirect laser photocoagulation for prethreshold type 1 retinopathy of prematurity (ROP) and high-risk type 2 prethreshold ROP in comparison to conservatively managed low-risk prethreshold type 2 ROP.

Methods: A retrospective analysis was carried out on infants screened for ROP between the years 2015 and 2020. Surviving children who had developed ROP in one or both eyes and received diode laser photocoagulation and those with conservatively managed regressed type 2 ROP who underwent at least one cycloplegic retinoscopy were included in the study.

Results: A total of 144 patients were screened for ROP between 2015 and 2020 at our institution. One hundred and thirty patients (260 eyes) fulfilled the study criteria and were included in this study. The treated group consisted of 132 eyes of 66 infants, of which 38 (14.6%) eyes had prethreshold type 1 ROP while 94 (36.2%) eyes had high-risk prethreshold type 2. The nontreated control group consisted of 128 (49.2%) eyes of 64 infants with low-risk type 2 prethreshold ROP. Earlier prematurity was found to be a significant determinant of the mean change in spherical equivalent among different gestational age groups (P = 0.035). In our cohort, we found that myopia is significantly related to Zone II ROP in comparison to Zone III ROP in the treated eyes (22% vs. 9%) (P = 0.002). No statistically significant difference was found in the final refraction among the treated eyes in relation to the birth weight or stage of prematurity.

Conclusion: In the present study, the majority of patients who were treated with diode laser for ROP had favorable anatomical and refractive outcomes. In contrast to previous studies that had suggested a trend toward myopia in laser-treated patients, in our study, the majority (71%) were hyperopes. This study suggests that other factors such as the stage and zone of ROP possibly contribute more to the development of myopia than the laser photocoagulation itself.

目的:本研究旨在评估因阈值前1型早产儿视网膜病变(ROP)和高风险阈值前2型早产儿视网膜病变而接受间接激光光凝治疗的患者的屈光疗效,并与保守治疗的低风险阈值前2型早产儿视网膜病变进行比较:对 2015 年至 2020 年期间筛查出 ROP 的婴儿进行了回顾性分析。研究纳入了单眼或双眼发生 ROP 并接受二极管激光光凝治疗的存活儿童,以及接受过至少一次环形视网膜镜检查的保守治疗的消退型 2 型 ROP 患儿:2015年至2020年间,我院共筛查了144名ROP患者。130名患者(260只眼)符合研究标准,被纳入本研究。治疗组包括 66 名婴儿的 132 只眼睛,其中 38 只(14.6%)眼睛为阈值前 1 型 ROP,94 只(36.2%)眼睛为高风险阈值前 2 型 ROP。未接受治疗的对照组包括 64 名婴儿的 128 只眼睛(49.2%),这些婴儿患有低风险 2 型阈值前视网膜病变。研究发现,早产是不同胎龄组球面等值平均值变化的重要决定因素(P = 0.035)。在我们的队列中,我们发现在接受治疗的眼睛中,近视与 II 区 ROP 的关系显著高于 III 区 ROP(22% 对 9%)(P = 0.002)。在接受治疗的眼睛中,最终屈光度与出生体重或早产阶段没有统计学意义上的差异:结论:在本研究中,大多数接受二极管激光治疗的早产儿视网膜病变患者都获得了良好的解剖和屈光效果。以往的研究表明,接受激光治疗的患者有近视的趋势,而在我们的研究中,大多数患者(71%)都是远视。这项研究表明,与激光光凝本身相比,ROP 的分期和分区等其他因素可能更容易导致近视的发生。
{"title":"Refractive Changes among Diode Laser-treated Retinopathy of Prematurity Patients: A Retrospective Study.","authors":"Lujain Alqurashi, Albaraa Alfaraidi, Faeeqah Almahmoudi, Enam Danish, Manal Hadrawi","doi":"10.4103/meajo.meajo_117_23","DOIUrl":"10.4103/meajo.meajo_117_23","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to assess the refractive outcomes of patients who underwent indirect laser photocoagulation for prethreshold type 1 retinopathy of prematurity (ROP) and high-risk type 2 prethreshold ROP in comparison to conservatively managed low-risk prethreshold type 2 ROP.</p><p><strong>Methods: </strong>A retrospective analysis was carried out on infants screened for ROP between the years 2015 and 2020. Surviving children who had developed ROP in one or both eyes and received diode laser photocoagulation and those with conservatively managed regressed type 2 ROP who underwent at least one cycloplegic retinoscopy were included in the study.</p><p><strong>Results: </strong>A total of 144 patients were screened for ROP between 2015 and 2020 at our institution. One hundred and thirty patients (260 eyes) fulfilled the study criteria and were included in this study. The treated group consisted of 132 eyes of 66 infants, of which 38 (14.6%) eyes had prethreshold type 1 ROP while 94 (36.2%) eyes had high-risk prethreshold type 2. The nontreated control group consisted of 128 (49.2%) eyes of 64 infants with low-risk type 2 prethreshold ROP. Earlier prematurity was found to be a significant determinant of the mean change in spherical equivalent among different gestational age groups (<i>P</i> = 0.035). In our cohort, we found that myopia is significantly related to Zone II ROP in comparison to Zone III ROP in the treated eyes (22% vs. 9%) (<i>P</i> = 0.002). No statistically significant difference was found in the final refraction among the treated eyes in relation to the birth weight or stage of prematurity.</p><p><strong>Conclusion: </strong>In the present study, the majority of patients who were treated with diode laser for ROP had favorable anatomical and refractive outcomes. In contrast to previous studies that had suggested a trend toward myopia in laser-treated patients, in our study, the majority (71%) were hyperopes. This study suggests that other factors such as the stage and zone of ROP possibly contribute more to the development of myopia than the laser photocoagulation itself.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 1","pages":"37-43"},"PeriodicalIF":0.6,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10903714/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Topography and Choroidal Thickness Measurement in Healthy Asian Indian Subjects using RTVue XR 100 Optical Coherence Tomography. 使用 RTVue XR 100 光学相干断层扫描测量健康亚裔印度人的地形图和脉络膜厚度。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2024-01-22 eCollection Date: 2023-01-01 DOI: 10.4103/meajo.meajo_89_23
Tarannum Mansoori, Aknoor S R Charan, Balakrishna Nagalla

Purpose: The purpose was to study the choroidal thickness and its profile, derived from different point locations in healthy Asian Indian subjects using RTVue XR 100 optical coherence tomography (OCT) and to determine its correlation with age, refractive error, and axial length.

Methods: In this cross-sectional study, 300 eyes of 150 healthy subjects, with no ocular pathology, were scanned in a single session, using a line scan protocol of RTVue XR 100 OCT. Choroidal thickness was measured at the subfoveal region, and six measurements were obtained on either side of the fovea (temporal and nasal) at 500 μm interval apart, up to 3000 μm. The correlation between subfoveal choroidal thickness and age, refractive error, and axial length was assessed.

Results: Three hundred eyes of 150 healthy subjects were included in the analysis. Median age of the study participants was 55 years (interquartile range [IQR]: 44-61). The median subfoveal choroidal thickness was 235 μm (IQR: 210-263). The choroidal thickness was minimum at nasal 3000 μm from the fovea, while it was maximum in the subfoveal region. The point zones which were near the fovea showed thicker choroidal thickness than the outer zones, both nasally and temporally (P < 0.00001 at all locations), and at all point locations the choroid were thicker temporally than nasally (All P < 0.00001). Subfoveal choroidal thickness showed negative correlation with age (coefficient = -0.62, P = 0.03) and axial length (correlation = -8.52, P = 0.02). A decrease in subfoveal choroidal thickness of 0.62 μm/year was found by regression analysis.

Conclusion: Our study provides normative database and topographic profile of choroidal thickness in the normal Asian Indian eyes using RTVue XR 100 OCT.

目的:使用 RTVue XR 100 光学相干断层扫描(OCT),研究健康的亚洲印度受试者不同点位置的脉络膜厚度及其轮廓,并确定其与年龄、屈光不正和轴长的相关性:在这项横断面研究中,使用 RTVue XR 100 OCT 的线扫描方案,对 150 名无眼部病变的健康受试者的 300 只眼睛进行了单次扫描。脉络膜厚度在眼窝下区域进行测量,并在眼窝两侧(颞侧和鼻侧)进行六次测量,每次间隔 500 μm,直至 3000 μm。评估了眼窝下脉络膜厚度与年龄、屈光不正和轴长之间的相关性:150名健康受试者的300只眼睛被纳入分析。研究对象的中位年龄为 55 岁(四分位距[IQR]:44-61)。中位眼底脉络膜厚度为 235 微米(IQR:210-263)。脉络膜厚度在距离眼窝 3000 μm 的鼻侧最小,而在眼窝下区域最大。在靠近眼窝的点区,脉络膜厚度在鼻侧和时间上都比外侧厚(所有位置的 P 均小于 0.00001),在所有点区,脉络膜在时间上都比鼻侧厚(所有位置的 P 均小于 0.00001)。眼底脉络膜厚度与年龄(系数 = -0.62,P = 0.03)和轴向长度(相关系数 = -8.52,P = 0.02)呈负相关。通过回归分析发现,眼底脉络膜厚度每年减少 0.62 μm:我们的研究提供了正常亚洲印度人眼睛脉络膜厚度的标准数据库和地形剖面图,使用的是 RTVue XR 100 OCT。
{"title":"Topography and Choroidal Thickness Measurement in Healthy Asian Indian Subjects using RTVue XR 100 Optical Coherence Tomography.","authors":"Tarannum Mansoori, Aknoor S R Charan, Balakrishna Nagalla","doi":"10.4103/meajo.meajo_89_23","DOIUrl":"10.4103/meajo.meajo_89_23","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose was to study the choroidal thickness and its profile, derived from different point locations in healthy Asian Indian subjects using RTVue XR 100 optical coherence tomography (OCT) and to determine its correlation with age, refractive error, and axial length.</p><p><strong>Methods: </strong>In this cross-sectional study, 300 eyes of 150 healthy subjects, with no ocular pathology, were scanned in a single session, using a line scan protocol of RTVue XR 100 OCT. Choroidal thickness was measured at the subfoveal region, and six measurements were obtained on either side of the fovea (temporal and nasal) at 500 μm interval apart, up to 3000 μm. The correlation between subfoveal choroidal thickness and age, refractive error, and axial length was assessed.</p><p><strong>Results: </strong>Three hundred eyes of 150 healthy subjects were included in the analysis. Median age of the study participants was 55 years (interquartile range [IQR]: 44-61). The median subfoveal choroidal thickness was 235 μm (IQR: 210-263). The choroidal thickness was minimum at nasal 3000 μm from the fovea, while it was maximum in the subfoveal region. The point zones which were near the fovea showed thicker choroidal thickness than the outer zones, both nasally and temporally (<i>P</i> < 0.00001 at all locations), and at all point locations the choroid were thicker temporally than nasally (All <i>P</i> < 0.00001). Subfoveal choroidal thickness showed negative correlation with age (coefficient = -0.62, <i>P</i> = 0.03) and axial length (correlation = -8.52, <i>P</i> = 0.02). A decrease in subfoveal choroidal thickness of 0.62 μm/year was found by regression analysis.</p><p><strong>Conclusion: </strong>Our study provides normative database and topographic profile of choroidal thickness in the normal Asian Indian eyes using RTVue XR 100 OCT.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 1","pages":"19-23"},"PeriodicalIF":0.6,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10903710/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bibliometric Analysis of Ophthalmology Publications from Arab Countries between 2012 and 2022. 2012 年至 2022 年阿拉伯国家眼科出版物的文献计量分析。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2024-01-22 eCollection Date: 2023-01-01 DOI: 10.4103/meajo.meajo_74_23
Angeli C Yu, Enrico Zauli, Loretta Missiroli, Massimo Busin

Purpose: The purpose of this study was to conduct a bibliometric analysis of articles published in Ophthalmology Journals from Arab countries from 2012 to 2022.

Methods: This cross-sectional analysis of all original ophthalmology research and review articles published by authors with an affiliation with an institution from Arab countries and indexed in the ISI Web of Science between January 2012 and December 2022.

Results: For the years 2012-2022, 4292 articles published in Ophthalmology Journals by authors from Arab-based institutions were identified. A 2.11-fold progressive increase in the number of publications was observed over the last decade with a substantial increase in publication volume during the first 2 years of the COVID-19 pandemic. The countries with the highest number of publications were Egypt (38.51%), Saudi Arabia (35.56%), and the United Arab Emirates (7.88%). According to affiliation, authors from King Khaled Eye Specialist Hospital (KKESH) (n = 644) published the highest number of ophthalmology articles, followed by King Saud University (n = 585) and Cairo University (n = 393).

Conclusion: Over the last decade, the overall productivity of research in the field of ophthalmology has significantly increased. Majority of the articles in ophthalmology were published by authors from Egypt and Saudi Arabia with KKESH as the most productive institution among Arab nations.

目的:本研究旨在对2012年至2022年阿拉伯国家在眼科期刊上发表的文章进行文献计量分析:本研究对 2012 年 1 月至 2022 年 12 月期间阿拉伯国家中与某机构有隶属关系的作者发表的、被 ISI 科学网收录的所有原创眼科研究和综述文章进行了横向分析:结果:2012 年至 2022 年期间,阿拉伯国家机构的作者在眼科期刊上发表了 4292 篇文章。在过去十年中,发表文章的数量逐渐增加了 2.11 倍,在 COVID-19 大流行的头两年,发表文章的数量大幅增加。发表论文数量最多的国家是埃及(38.51%)、沙特阿拉伯(35.56%)和阿拉伯联合酋长国(7.88%)。根据隶属关系,来自哈立德国王眼科专科医院(KKESH)(n = 644)的作者发表的眼科文章数量最多,其次是沙特国王大学(n = 585)和开罗大学(n = 393):结论:在过去十年中,眼科领域的总体研究效率显著提高。眼科领域的大部分文章都是由埃及和沙特阿拉伯的作者发表的,而 KKESH 是阿拉伯国家中发表论文最多的机构。
{"title":"Bibliometric Analysis of Ophthalmology Publications from Arab Countries between 2012 and 2022.","authors":"Angeli C Yu, Enrico Zauli, Loretta Missiroli, Massimo Busin","doi":"10.4103/meajo.meajo_74_23","DOIUrl":"10.4103/meajo.meajo_74_23","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to conduct a bibliometric analysis of articles published in Ophthalmology Journals from Arab countries from 2012 to 2022.</p><p><strong>Methods: </strong>This cross-sectional analysis of all original ophthalmology research and review articles published by authors with an affiliation with an institution from Arab countries and indexed in the ISI Web of Science between January 2012 and December 2022.</p><p><strong>Results: </strong>For the years 2012-2022, 4292 articles published in Ophthalmology Journals by authors from Arab-based institutions were identified. A 2.11-fold progressive increase in the number of publications was observed over the last decade with a substantial increase in publication volume during the first 2 years of the COVID-19 pandemic. The countries with the highest number of publications were Egypt (38.51%), Saudi Arabia (35.56%), and the United Arab Emirates (7.88%). According to affiliation, authors from King Khaled Eye Specialist Hospital (KKESH) (<i>n</i> = 644) published the highest number of ophthalmology articles, followed by King Saud University (<i>n</i> = 585) and Cairo University (<i>n</i> = 393).</p><p><strong>Conclusion: </strong>Over the last decade, the overall productivity of research in the field of ophthalmology has significantly increased. Majority of the articles in ophthalmology were published by authors from Egypt and Saudi Arabia with KKESH as the most productive institution among Arab nations.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 1","pages":"1-5"},"PeriodicalIF":0.6,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10903712/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corneal Endothelial Toxicity Secondary to Topical 5-fluorouracil. 继发于局部 5-氟尿嘧啶的角膜内皮毒性
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2024-01-22 eCollection Date: 2023-01-01 DOI: 10.4103/meajo.meajo_33_23
Ahmed Alsaleh, Abdulrahman Alfarhan

5-fluorouracil (5-FU) is an important chemotherapy adjunct for the management of conjunctival and corneal dysplasia. Since it is possible for this agent to gain access to the anterior chamber, several reports in the literature have demonstrated 5-FU long-term safety and efficacy. Although recent publications reported that topical 5-FU has no cytotoxic effect on the corneal endothelium, we report a patient affected by bilateral ocular surface squamous neoplasia who has developed significant endothelial density and morphology changes after starting a course of 5-FU.

5-氟尿嘧啶(5-FU)是治疗结膜和角膜发育不良的重要化疗辅助药物。由于这种药剂有可能进入前房,因此有多篇文献报道证实了 5-FU 的长期安全性和有效性。虽然最近有文献报道局部使用 5-FU 对角膜内皮没有细胞毒性作用,但我们报告了一名双侧眼表鳞状上皮瘤患者在开始使用 5-FU 疗程后,角膜内皮密度和形态发生了显著变化。
{"title":"Corneal Endothelial Toxicity Secondary to Topical 5-fluorouracil.","authors":"Ahmed Alsaleh, Abdulrahman Alfarhan","doi":"10.4103/meajo.meajo_33_23","DOIUrl":"10.4103/meajo.meajo_33_23","url":null,"abstract":"<p><p>5-fluorouracil (5-FU) is an important chemotherapy adjunct for the management of conjunctival and corneal dysplasia. Since it is possible for this agent to gain access to the anterior chamber, several reports in the literature have demonstrated 5-FU long-term safety and efficacy. Although recent publications reported that topical 5-FU has no cytotoxic effect on the corneal endothelium, we report a patient affected by bilateral ocular surface squamous neoplasia who has developed significant endothelial density and morphology changes after starting a course of 5-FU.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 1","pages":"55-58"},"PeriodicalIF":0.6,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10903716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative and Intraoperative Spontaneous Scleral Rupture: A Case Report and Review of Literature. 术前和术中自发性巩膜破裂:病例报告和文献综述。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2024-01-22 eCollection Date: 2023-01-01 DOI: 10.4103/meajo.meajo_71_23
Mohammed AlAmry, Esraa Alahareef, Abdulrahamn Aljebreen, Ramzi AlJudaibi

Scleral rupture is a rare but significant complication that can occur due to multiple risk factors. In this report, we discuss two instances of scleral perforation that happened during a silicone oil injection and after a peribulbar injection. Our study suggests that prior ocular surgery is a further risk factor for intraoperative scleral rupture, and more investigation is required to identify additional relevant risk factors that weaken the sclera.

巩膜破裂是一种罕见但严重的并发症,可因多种风险因素而发生。在本报告中,我们讨论了两例巩膜穿孔,分别发生在硅油注射过程中和眼周注射后。我们的研究表明,之前的眼科手术是导致术中巩膜破裂的另一个危险因素,因此需要进行更多的调查,以确定导致巩膜变薄的其他相关危险因素。
{"title":"Preoperative and Intraoperative Spontaneous Scleral Rupture: A Case Report and Review of Literature.","authors":"Mohammed AlAmry, Esraa Alahareef, Abdulrahamn Aljebreen, Ramzi AlJudaibi","doi":"10.4103/meajo.meajo_71_23","DOIUrl":"10.4103/meajo.meajo_71_23","url":null,"abstract":"<p><p>Scleral rupture is a rare but significant complication that can occur due to multiple risk factors. In this report, we discuss two instances of scleral perforation that happened during a silicone oil injection and after a peribulbar injection. Our study suggests that prior ocular surgery is a further risk factor for intraoperative scleral rupture, and more investigation is required to identify additional relevant risk factors that weaken the sclera.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 1","pages":"59-61"},"PeriodicalIF":0.6,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10903711/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single Low-dose Suprachoroidal Triamcinolone Acetonide Injection in Macular Edema Secondary to Noninfectious Posterior Uveitis. 单次低剂量脉络膜上曲安奈德注射治疗非感染性后葡萄膜炎继发的黄斑水肿
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2024-01-22 eCollection Date: 2023-01-01 DOI: 10.4103/meajo.meajo_78_21
Abhishek Anand, Shivani Sinha, Abhishek Gupta, Srishtee Shree, Anita Ambasta, Bibhuti P Sinha, Rajvardhan Azad

Purpose: The purpose was to study the anatomical and functional outcome following single low-dose suprachoroidal triamcinolone acetonide (LD-SCTA) (2 mg) injection in noninfectious posterior uveitis.

Methods: Eleven patients with macular edema (ME) more than 280 μ secondary to noninfectious uveitis were included in the study. A single LD-SCTA (0.5 ml) injection was performed in the study eye with the help of a novel suprachoroidal microneedle (Pricon, Iscon Surgicals, Jodhpur, Rajasthan, India). The study parameters were noted at 4 and 12 weeks post LD-SCTA injection.

Results: Ten of 11 patients had a significant decrease in central macular thickness (CMT). The mean CMT measurement at baseline was 513.6 ± 191.73 μm for the 10 patients who responded to the treatment, which reduced significantly to 265.1 ± 34.72 μm (P < 0.003) and 260.6 ± 34.72 μm (P < 0.002) at 4 and 12 weeks, respectively. The mean best-corrected visual acuity (BCVA) at baseline was 0.84 ± 0.41 logMAR unit which improved to 0.52 ± 0.33 (P < 0.001) and 0.25 ± 0.22 (P < 0.000) at weeks 4 and 12, respectively. The mean intraocular pressure at baseline recorded was 16.36 ± 2.97 mmHg, 19.45 ± 4.80 mmHg (P = 0.06) at 4 weeks, and 17.27 ± 2.53 mmHg (P = 0.35) at 12 weeks. One eye which did not respond to LD-SCTA was a case of recurrent Vogt-Koyanagi-Harada disease.

Conclusion: Single LD-SCTA injection is efficacious in reducing CMT in ME, improving BCVA, and controlling the inflammation in noninfectious posterior uveitis. LD-SCTA can be used as a first-line therapy in noninfectious uveitis over other routes of steroid administration with a favorable outcome and safety profile.

目的:研究非感染性后葡萄膜炎单次低剂量脉络膜上曲安奈德(LD-SCTA)(2 mg)注射后的解剖和功能结果:研究共纳入了11名继发于非感染性葡萄膜炎、黄斑水肿(ME)超过280 μ的患者。在新型脉络膜上微针(Pricon,Iscon Surgicals,Jodhpur,Rajasthan,India)的帮助下,对研究眼进行单次 LD-SCTA 注射(0.5 毫升)。研究参数在注射 LD-SCTA 后 4 周和 12 周进行记录:结果:11 名患者中有 10 人的黄斑中心厚度(CMT)明显下降。对治疗有反应的 10 名患者基线时的平均黄斑中心厚度测量值为 513.6 ± 191.73 μm,4 周和 12 周时分别显著降至 265.1 ± 34.72 μm(P < 0.003)和 260.6 ± 34.72 μm(P < 0.002)。基线时的平均最佳矫正视力(BCVA)为 0.84 ± 0.41 logMAR 单位,第 4 周和第 12 周时分别提高到 0.52 ± 0.33(P < 0.001)和 0.25 ± 0.22(P < 0.000)。基线记录的平均眼压为 16.36 ± 2.97 mmHg,4 周时为 19.45 ± 4.80 mmHg(P = 0.06),12 周时为 17.27 ± 2.53 mmHg(P = 0.35)。一只对 LD-SCTA 无反应的眼为复发性 Vogt-Koyanagi-Harada 病例:结论:单次注射 LD-SCTA 可有效减少 ME 的 CMT,改善 BCVA,控制非感染性后葡萄膜炎的炎症。LD-SCTA可作为非感染性葡萄膜炎的一线疗法,优于其他类固醇给药途径,并具有良好的疗效和安全性。
{"title":"Single Low-dose Suprachoroidal Triamcinolone Acetonide Injection in Macular Edema Secondary to Noninfectious Posterior Uveitis.","authors":"Abhishek Anand, Shivani Sinha, Abhishek Gupta, Srishtee Shree, Anita Ambasta, Bibhuti P Sinha, Rajvardhan Azad","doi":"10.4103/meajo.meajo_78_21","DOIUrl":"10.4103/meajo.meajo_78_21","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose was to study the anatomical and functional outcome following single low-dose suprachoroidal triamcinolone acetonide (LD-SCTA) (2 mg) injection in noninfectious posterior uveitis.</p><p><strong>Methods: </strong>Eleven patients with macular edema (ME) more than 280 μ secondary to noninfectious uveitis were included in the study. A single LD-SCTA (0.5 ml) injection was performed in the study eye with the help of a novel suprachoroidal microneedle (Pricon, Iscon Surgicals, Jodhpur, Rajasthan, India). The study parameters were noted at 4 and 12 weeks post LD-SCTA injection.</p><p><strong>Results: </strong>Ten of 11 patients had a significant decrease in central macular thickness (CMT). The mean CMT measurement at baseline was 513.6 ± 191.73 μm for the 10 patients who responded to the treatment, which reduced significantly to 265.1 ± 34.72 μm (<i>P</i> < 0.003) and 260.6 ± 34.72 μm (<i>P</i> < 0.002) at 4 and 12 weeks, respectively. The mean best-corrected visual acuity (BCVA) at baseline was 0.84 ± 0.41 logMAR unit which improved to 0.52 ± 0.33 (<i>P</i> < 0.001) and 0.25 ± 0.22 (<i>P</i> < 0.000) at weeks 4 and 12, respectively. The mean intraocular pressure at baseline recorded was 16.36 ± 2.97 mmHg, 19.45 ± 4.80 mmHg (<i>P</i> = 0.06) at 4 weeks, and 17.27 ± 2.53 mmHg (<i>P</i> = 0.35) at 12 weeks. One eye which did not respond to LD-SCTA was a case of recurrent Vogt-Koyanagi-Harada disease.</p><p><strong>Conclusion: </strong>Single LD-SCTA injection is efficacious in reducing CMT in ME, improving BCVA, and controlling the inflammation in noninfectious posterior uveitis. LD-SCTA can be used as a first-line therapy in noninfectious uveitis over other routes of steroid administration with a favorable outcome and safety profile.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 1","pages":"6-12"},"PeriodicalIF":0.6,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10903718/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parent's Awareness of Preventive Measures for Digital Eye Strain Syndrome among Saudi Students after 1 Year of Online Studies - A Survey. 沙特学生在线学习一年后家长对数码眼疲劳综合症预防措施的认识--一项调查。
IF 0.6 Q4 OPHTHALMOLOGY Pub Date : 2024-01-22 eCollection Date: 2023-01-01 DOI: 10.4103/meajo.meajo_72_22
Dora H AlHarkan

Purpose: The digital eye strain (DES) is of public health magnitude in students undertaking online studies during the COVID-19 pandemic. The DES prevention strategies will be effective if all stakeholders, including parents, work together. We present an awareness level of preventive measures among parents of students studying online for 1 year.

Methods: This web-based survey was held in December 2021. Parents of Saudi students in the Qassim region responded to 15 questions about the preventive measures for DES. The responses were summed up and graded into very poor, poor, good, and excellent. The level of awareness was associated with determinants.

Results: The awareness was excellent in 566 of 704 (80.4%) (95% confidence interval 77.5-83.3) participants. Parents had poor awareness about the importance of the 20-20-20 rule (43.8%), frequent blinking (56.7%), using digital devices beyond studies (57.4%), using eye lubricants while using a digital device (56%), and using devices at night in lying position (69.6%). Excellent awareness was significantly associated with primary-level students (P = 0.0004), those having ophthalmic consultation in the past (P = 0.02), and students with DES (P = 0.0006). Parents with excellent awareness were not satisfied with online studies of their wards (P = 0.001).

Conclusion: Awareness of parents about preventive measures to address DES in students is relatively high. However, health promotion is recommended, especially focusing on the weak areas to improve DES and its impact on students.

目的:在 COVID-19 大流行期间,数字眼疲劳(DES)在进行在线学习的学生中具有公共卫生意义。如果包括家长在内的所有利益相关者共同努力,DES 预防策略就会有效。我们介绍了在线学习一年的学生家长对预防措施的认识水平:这项网络调查于 2021 年 12 月进行。卡西姆地区的沙特学生家长回答了有关 DES 预防措施的 15 个问题。调查结果汇总后分为很差、差、好和优。认识水平与决定因素相关联:在 704 名参与者中,有 566 人(80.4%)(95% 置信区间为 77.5-83.3)的认识水平为优秀。家长对 20-20-20 规则的重要性(43.8%)、频繁眨眼(56.7%)、在学习之外使用数码设备(57.4%)、使用数码设备时使用眼部润滑剂(56%)和夜间躺着使用设备(69.6%)的认识不足。认知度高的学生与小学生(P = 0.0004)、过去接受过眼科咨询的学生(P = 0.02)和患有 DES 的学生(P = 0.0006)有明显相关性。认知度高的家长对其被监护人的在线学习不满意(P = 0.001):结论:家长对学生 DES 预防措施的认识相对较高。结论:家长对解决学生 DES 问题的预防措施的认识相对较高,但建议开展健康宣传,特别是针对薄弱环节,以改善 DES 及其对学生的影响。
{"title":"Parent's Awareness of Preventive Measures for Digital Eye Strain Syndrome among Saudi Students after 1 Year of Online Studies - A Survey.","authors":"Dora H AlHarkan","doi":"10.4103/meajo.meajo_72_22","DOIUrl":"10.4103/meajo.meajo_72_22","url":null,"abstract":"<p><strong>Purpose: </strong>The digital eye strain (DES) is of public health magnitude in students undertaking online studies during the COVID-19 pandemic. The DES prevention strategies will be effective if all stakeholders, including parents, work together. We present an awareness level of preventive measures among parents of students studying online for 1 year.</p><p><strong>Methods: </strong>This web-based survey was held in December 2021. Parents of Saudi students in the Qassim region responded to 15 questions about the preventive measures for DES. The responses were summed up and graded into very poor, poor, good, and excellent. The level of awareness was associated with determinants.</p><p><strong>Results: </strong>The awareness was excellent in 566 of 704 (80.4%) (95% confidence interval 77.5-83.3) participants. Parents had poor awareness about the importance of the 20-20-20 rule (43.8%), frequent blinking (56.7%), using digital devices beyond studies (57.4%), using eye lubricants while using a digital device (56%), and using devices at night in lying position (69.6%). Excellent awareness was significantly associated with primary-level students (<i>P</i> = 0.0004), those having ophthalmic consultation in the past (<i>P</i> = 0.02), and students with DES (<i>P</i> = 0.0006). Parents with excellent awareness were not satisfied with online studies of their wards (<i>P</i> = 0.001).</p><p><strong>Conclusion: </strong>Awareness of parents about preventive measures to address DES in students is relatively high. However, health promotion is recommended, especially focusing on the weak areas to improve DES and its impact on students.</p>","PeriodicalId":18740,"journal":{"name":"Middle East African Journal of Ophthalmology","volume":"30 1","pages":"13-18"},"PeriodicalIF":0.6,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10903719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140022239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Middle East African Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1